• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
NewslettersBrainstorm Health

The Diseases That Are Increasingly Killing Americans: Brainstorm Health

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
August 27, 2019, 8:03 PM ET

Good afternoon, readers.

A new study in the journal JAMA helps break out exactly what is, and isn’t, killing Americans.

Heart disease is far and away the number one killer in this country (some 1 in 4 deaths are associated with it). But cancer, lung diseases, and metabolic disorders such as diabetes aren’t far behind.

Here is the good news-bad news situation, according to the report: “While cardiovascular disease (CVD) death rates declined by approximately 36% from 2000 to 2014, CVD remains the leading cause of mortality among US adults. Annual declines in CVD mortality slowed between 2011 and 2014 (0.7% fewer CVD deaths per year), and it appears unlikely that strategic goals from the American Heart Association (20% reduction by 2020) will be achieved.”

Put into simpler terms, diabetes and high blood pressure are still killing millions of people. And communities of color continue to be disproportionately affected by this reality.

Read on for the day’s news.

Sy Mukherjee, @the_sy_guy, sayak.mukherjee@fortune.com

DIGITAL HEALTH

Peloton goes from confidential IPO to actual IPO. The digitally-connected exercise firm Peloton (the one with the fancy, in-home bikes and treadmills that connect you online with coaches) is going public (again... sort of). Peloton had already filed for a confidential IPO earlier this year. But now it's going the whole hog and filing for a Nasdaq public offering. The year of the digital health IPO continues!  (Fortune)

INDICATIONS

Investors seem pretty OK with the J&J opioid ruling. Shareholders don't appear to be sweating the $500 million-plus judgment levied against Johnson & Johnson for its alleged role in fueling the opioid epidemic. J&J shares are up nearly 2% since the landmark ruling announced Monday, which has been seen as a milestone in dozens of cases levied against drug makers and distributors for aggressively selling pain products. Why? The decision (contested by J&J) could have involved significantly more money. (Fortune)

REQUIRED READING

Why 20,000 AT&T Workers Went on Strike, by Aaron Pressman

Hello, This Is Artificial Intelligence. How Can I Help You?by Jonathan Vanian

An Unwanted Side Effect for Tech Companies Going Public, by Rey Mashayekhi

Find past coverage. Sign up for other Fortune newsletters.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Newsletters

NewslettersMPW Daily
Female exec moves to watch this week, from Binance to Supergoop
By Emma HinchliffeDecember 5, 2025
3 days ago
NewslettersCFO Daily
Gen Z fears AI will upend careers. Can leaders change the narrative?
By Sheryl EstradaDecember 5, 2025
3 days ago
NewslettersTerm Sheet
Four key questions about OpenAI vs Google—the high-stakes tech matchup of 2026
By Alexei OreskovicDecember 5, 2025
3 days ago
Facebook CEO Mark Zuckerberg adjusts an avatar of himself during a company event in New York City on Thursday, Oct. 28, 2021. (Photo: Michael Nagle/Bloomberg/Getty Images)
NewslettersFortune Tech
Meta may unwind metaverse initiatives with layoffs
By Andrew NuscaDecember 5, 2025
3 days ago
Shuntaro Furukawa, president of Nintendo Co., speaks during a news conference in Osaka, Japan, on Thursday, April 25, 2019. Nintendo gave a double dose of disappointment by posting earnings below analyst estimates and signaled that it would not introduce a highly anticipated new model of the Switch game console at a June trade show. Photographer: Buddhika Weerasinghe/Bloomberg via Getty Images
NewslettersCEO Daily
Nintendo’s 98% staff retention rate means the average employee has been there 15 years
By Nicholas GordonDecember 5, 2025
3 days ago
AIEye on AI
Companies are increasingly falling victim to AI impersonation scams. This startup just raised $28M to stop deepfakes in real time
By Sharon GoldmanDecember 4, 2025
4 days ago

Most Popular

placeholder alt text
Real Estate
The 'Great Housing Reset' is coming: Income growth will outpace home-price growth in 2026, Redfin forecasts
By Nino PaoliDecember 6, 2025
2 days ago
placeholder alt text
AI
Nvidia CEO says data centers take about 3 years to construct in the U.S., while in China 'they can build a hospital in a weekend'
By Nino PaoliDecember 6, 2025
2 days ago
placeholder alt text
Economy
The most likely solution to the U.S. debt crisis is severe austerity triggered by a fiscal calamity, former White House economic adviser says
By Jason MaDecember 6, 2025
1 day ago
placeholder alt text
Economy
JPMorgan CEO Jamie Dimon says Europe has a 'real problem’
By Katherine Chiglinsky and BloombergDecember 6, 2025
1 day ago
placeholder alt text
Big Tech
Mark Zuckerberg rebranded Facebook for the metaverse. Four years and $70 billion in losses later, he’s moving on
By Eva RoytburgDecember 5, 2025
3 days ago
placeholder alt text
Politics
Supreme Court to reconsider a 90-year-old unanimous ruling that limits presidential power on removing heads of independent agencies
By Mark Sherman and The Associated PressDecember 7, 2025
15 hours ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.